Mani Mohindru, Novasenta CEO
July 29, 2022 07:00 AM EDTUpdated 09:42 AM
Financing
Startups

Ex­clu­sive: UPMC launch­es an­oth­er biotech, root­ed in the tu­mor mi­croen­vi­ron­ment

Kyle LaHucik

Senior Reporter

In Mani Mo­hin­dru’s telling, No­vasen­ta is “as biotech-y as you can get.”

The CEO of the lat­est start­up out of UPMC’s sprawl­ing re­search ap­pa­ra­tus …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

Rev­o­lu­tion Med­i­ci­nes' KRAS drug shows po­ten­tial in ear­ly cut of lung can­cer da­ta

Boehringer’s up­dat­ed re­sults in HER2-mu­tat­ed lung can­cer im­press

Ex­clu­sive: Can AI re­place an­i­mal test­ing? A new biotech launch­es to find out

France stops Val­neva's chikun­gun­ya vac­cine roll­out in over 65s af­ter safe­ty is­sue

Schol­ar Rock names new CEO, adds biotech vet­er­ans in C-suite re­build

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times